Delivery Order SPE2DB20D3103-SPE2DB24FM8H0
Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $92K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
- This federal contract award, valued at $90,498.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,834.08, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through March 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award, valued at $3,226.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product, to support U.S. government medical needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award, with a ceiling value of $5,401.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200mg/2ml vials, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $89,099.58, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $18,072.65, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. This is a firm fixed-price delivery order contract with a completion date of December 5, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,197.11, is for the delivery of 4558300264 - BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 1, 2022. This appears to be a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,683.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies and has an ultimate completion date of April 29, 2024. The contract is not designated with any set-aside requirements, indicating an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a ceiling value of $80,528.61 and is a delivery order contract with a firm fixed-price pricing type. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance ending on September 21, 2023. The contract was awarded on September 20, 2023, and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM8H0Delivery Order
This federal contract award, valued at $92,410.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through February 28, 2024. This contract award was made through full and open competition without any set-aside designation.
Generated 5/14/25, 10:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $92.4k | 2/27/24 |